An acute dose of morphine increased brain tryptophan in mice. 7 his effect was not prevented by naloxone nor was it produced by other narcotic analgesics. Dextrorphan, but not levorphanol. had a similar effect t o morphine. A large dose of tryptophan had no effect on the antinociceptive action of mo
The effect of tryptophan on brain 5-HT function: A review
โ Scribed by P. J. Cowen
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 498 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Administration of lโtryptophan (TRP), the amino acid precursor of 5โhydroxytryptamine (5โHT), to animals increases brain 5โHT synthesis and in some circumstances, the release of 5โHT in terminal fields. TRP also appears to increase brain 5โHT neurotransmission in humans because neuroendocrine studies have shown that intravenous TRP produces a doseโrelated increase in plasma prolactin concentration, probably via indirect stimulation of postsynaptic 5โHT~1A~ receptors. The effect of TRP on prolactin release in humans is enhanced by several effective antidepressant treatments including tricyclic antidepressants, selective 5โHT reโuptake inhibitors, monoamine oxidase inhibitors and lithium. The ability of these drugs to augment the effect of TRP on brain 5โHT function may represent the pharmacological mechanism that underpins the utility of TRP in combination drug treatments of refractory depression.
๐ SIMILAR VOLUMES
## Abstract ## Background Electroconvulsive therapy (ECT) as a single course or in maintenance form (MโECT) is an effective treatment in depressed elderly. However, ECT may have adverse effects on cognition. ## Objective To review all studies from 1980โ2006 on ECT and cognition in the elderly wi
Acute 17โค-estradiol treatment had been shown to downregulate the 5-HT 1A receptor mRNA expression in limbic areas of the female rat brain. The aim of the present study was to determine the effects of chronic 17โค-estradiol treatment on 5-HT 1A receptor mRNA expression and 5-HT 1A receptor binding in
This study investigated the effects of 8-OH-DPAT and various other 5-HT 1A receptor agonists on brain noradrenergic transmission using Fos-like immunoreactivity (Fos-LI) as a marker of neural activation. Administration of 8-OH-DPAT (0.1 and 1 mg/kg) induced a marked and dose-related increase in the